Besides, MIR31HG was observed to promote cell proliferation and cell cycle progression and inhibit cell apoptosis, and it could be a potential therapeutic target for head and neck squamous cell carcinoma in the study by Wang et al. (2018). The gene discussed is MIR31HG; the disease is head and neck squamous cell carcinoma.